ADGN 122
Alternative Names: ADGN-122Latest Information Update: 10 Jun 2024
At a glance
- Originator Aanastra
- Class Antineoplastics; Immunotherapies; RNA
- Mechanism of Action KRAS protein expression inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer